Szyfter Witold, Karlik Michał, Sekula Alicja, Harris Simon, Gawęcki Wojciech
Klinika Otolaryngologii i Onkologii Laryngologicznej Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu.
Klinika Foniatrii i Audiologii Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu.
Otolaryngol Pol. 2019 Apr 5;73(3):1-5. doi: 10.5604/01.3001.0013.1000.
Surgical treatment of deafness by cochlear implants is used for more than 40 years, and during this period permanently, gradual and significant expansion of indications for this surgery has been observed.
In our Department in the years 1994-2018 1480 cochlear implantations were performed, both in adults (647) and in children (883). In this study current indications and the rules for eligibility of patients based on 25 years of experience are presented.
Indications for cochlear implantation in adults are: 1) bilateral postlingual deafness, 2) bilateral sensorineural hearing loss - in pure tone audiometry > 70 dB HL (average 500-4000 Hz) and in speech audiometry in hearing aids understanding < 50% of words for the intensity of the stimulus 65 dB, in the absence of the benefits of hearing aids, 3) bilateral profound hearing loss for high frequency with good hearing for low frequency, in the absence of the benefits of hearing aids, 4) some cases of asymmetric hearing loss with intensive tinnitus in the deaf ear. An indication in children is bilateral sensorineural hearing loss > 80dB HL confirmed by hearing tests, after about 6 months of rehabilitation with the use of hearing aids.
Although cochlear implantation is used for more than 40 years, the indications for this treatment underlies constant modifications. They concern the age of eligible patients, implantation in patients with partially preserved hearing, as well as treatment for patients with difficult anatomical conditions. In many countries, bilateral implantations are commonly performed, and more and more centers recommend this treatment in the case of unilateral deafness or asymmetric hearing loss, especially with the accompanying tinnitus in the deaf ear.
人工耳蜗植入治疗耳聋已应用40多年,在此期间,该手术的适应证持续、逐步且显著地扩大。
1994年至2018年,我们科室共进行了1480例人工耳蜗植入手术,其中成人647例,儿童883例。本研究基于25年的经验,介绍了当前的适应证及患者入选标准。
成人人工耳蜗植入的适应证为:1)双侧语后聋;2)双侧感音神经性听力损失——纯音听力计检测>70dB HL(平均500 - 4000Hz),言语听力计检测中,在刺激强度为65dB时,使用助听器对言语的理解度<50%,且使用助听器无获益;3)双侧高频重度听力损失,低频听力良好,且使用助听器无获益;4)部分单侧听力损失且患侧伴有严重耳鸣的病例。儿童的适应证为:经听力测试确诊为双侧感音神经性听力损失>80dB HL,且在使用助听器康复约6个月后。
尽管人工耳蜗植入已应用40多年,但该治疗的适应证仍在不断修改。这些修改涉及符合条件患者的年龄、部分听力保留患者的植入,以及解剖条件复杂患者的治疗。在许多国家,双侧植入手术很常见,越来越多的中心推荐对单侧耳聋或不对称听力损失患者,尤其是患侧伴有耳鸣的患者进行这种治疗。